I would add, that if Mesoblast cannot get someone like the NIH to fund this additional COVID-19 ARDS trial with 27,000+ people dying of COVID-19 in the last 14 days in the USA, then IMO this would not be a confidence booster for this indication
2+ years into this pandemic and the daily/weekly/fortnightly death toll still at ridiculous levels is quite sad
https://www.worldometers.info/coronavirus/weekly-trends/#weekly_table
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-104
-
- There are more pages in this discussion • 802 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.335M | 3.675M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 42955 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 26078 | 5 |
View Market Depth
| Last trade - 13.56pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |